Published in Oncology Business Week, October 12th, 2008
The core set of cancer cell lines developed by the Cancer Genome Project includes samples from most types of human cancer. Combined with more than 400 normal control samples, nearly 1,250 were analyzed using Affymetrix technology. The SNP Array 6.0 features more than 1.8 million markers for genetic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.